spacer
home > ebr > autumn 2009 > designer therapeutic proteins
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

 
News and Press Releases

Abzena hires Matthew Stober to lead the company through the next phase of global growth

San Diego, CA, 10th January 2023 – Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced today that Matthew Stober has joined as their new Chief Executive Officer.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page
Send to a friend
Privacy statement